Y-Intercept (Hong Kong) Ltd

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1772875 HONG KONG, K3

Position in TEVA

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$9,126,209

+$6,880,050 QoQ

Shares Held

302,995

+172.5% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Y-Intercept (Hong Kong) Ltd holds $31,681,893 across 15 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (28.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd This page	302,995	$9,126,209
2	VTRS	Viatris Inc	525,863	$7,104,409
3	PRGO	PERRIGO Co plc	447,451	$4,805,623
4	BIOA	BioAge Labs, Inc.	201,337	$3,521,384
5	ZTS	Zoetis Inc.	15,837	$1,872,091
6	SUPN	Supernus Pharmaceuticals, Inc.	20,236	$1,045,998
7	HLN	Haleon plc	93,822	$939,158
8	XERS	Xeris Biopharma Holdings, Inc.	161,793	$938,399

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,126,209	302,995	+172.5%	Shares	Sole	2026-04-27
2025-09-30	$2,246,159	111,196	+777.2%	Shares	Sole	2025-10-31
2025-06-30	$212,449	12,676	-93.4%	Shares	Sole	2025-08-01
2025-03-31	$2,972,358	193,387	+48.6%	Shares	Sole	2025-05-06
2024-12-31	$2,868,417	130,146	+277.3%	Shares	Sole	2025-02-04
2024-06-30	$560,511	34,493	-34.6%	Shares	Sole	2024-08-14
2023-06-30	$397,162	52,744	-48.1%	Shares	Sole	2023-08-14
2022-12-31	$926,883	101,632	-30.1%	Shares	Sole	2023-02-14
2022-03-31	$1,365,409	145,411	+29.7%	Shares	Sole	2022-05-16
2021-09-30	$1,092,350	112,151	+721.7%	Shares	Sole	2021-11-15
2021-03-31	$157,509	13,649	—	Shares	Sole	2021-05-12
No filing history on record for this holder in this stock.